+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Age-Related Macular Degeneration Market and Competitive Landscape - 2020

  • ID: 5023586
  • Report
  • April 2020
  • Region: Europe
  • Fore Pharma
1 of 2
The research report Europe Age-Related Macular Degeneration Market and Competitive Landscape - 2020, provides comprehensive insights into the Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecasts the Age-Related Macular Degeneration market size and drug sales. It also provides insights into Age-Related Macular Degeneration epidemiology and late stage pipeline.

This research covers the following: Age-Related Macular Degeneration treatment options, Age-Related Macular Degeneration late stage clinical trials pipeline, Age-Related Macular Degeneration prevalence by countries, Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries Germany, France, Italy, Spain, UK, Europe (EU5 Countries).

Research Scope:
  • Countries: Germany, France, Italy, Spain, UK, Europe
  • Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Age-Related Macular Degeneration by development phase 3, phase 2, and phase 1, by pharmacological class and company
  • Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Age-Related Macular Degeneration by countries
  • Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
  • Age-Related Macular Degeneration drugs sales: Find out the sales value for Age-Related Macular Degeneration drugs by countries
  • Age-Related Macular Degeneration market valuations: Find out the market size for Age-Related Macular Degeneration drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2024
  • Age-Related Macular Degeneration drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research:
  • Evaluate commercial market opportunities for Age-Related Macular Degeneration drugs
  • Synthesize insights for business development & licensing
  • Track market size, competitor drug sales, market shares in the Age-Related Macular Degeneration market
  • Develop in-depth knowledge of competition and markets
  • Analyze Age-Related Macular Degeneration drug sales data to update your brand planning trackers
  • Develop tactics and strategies to take advantage of opportunities in the market
  • Track Market Events and Trends and analyze key events in the Age-Related Macular Degeneration market
  • Develop forecast models, healthcare frameworks, or economic models
  • Answer key business questions; supports decision making in R&D to long term marketing strategies

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 2
1. Age-Related Macular Degeneration Treatment Options

2. Age-Related Macular Degeneration Pipeline Insights
2.1. Age-Related Macular Degeneration Phase 3 Clinical Trials
2.2. Age-Related Macular Degeneration Phase 2 Clinical Trials
2.3. Age-Related Macular Degeneration Phase 1 Clinical Trials

3. Age-Related Macular Degeneration Epidemiology Analysis by Countries

4. Germany Age-Related Macular Degeneration Market Insights
4.1. Marketed Drugs for Age-Related Macular Degeneration in Germany
4.2. Germany Age-Related Macular Degeneration Market Size & Forecast
4.3. Germany Age-Related Macular Degeneration Drugs Sales Forecast
4.4. Germany Age-Related Macular Degeneration Market Share Analysis

5. France Age-Related Macular Degeneration Market Insights
5.1. Marketed Drugs for Age-Related Macular Degeneration in France
5.2. France Age-Related Macular Degeneration Market Size & Forecast
5.3. France Age-Related Macular Degeneration Product Sales Forecast
5.4. France Age-Related Macular Degeneration Market Share Analysis

6. Italy Age-Related Macular Degeneration Market Insights
6.1. Marketed Drugs for Age-Related Macular Degeneration in Italy
6.2. Italy Age-Related Macular Degeneration Market Size & Forecast
6.3. Italy Age-Related Macular Degeneration Product Sales Forecast
6.4. Italy Age-Related Macular Degeneration Market Share Analysis

7. Spain Age-Related Macular Degeneration Market Insights
7.1. Marketed Drugs for Age-Related Macular Degeneration in Spain
7.2. Spain Age-Related Macular Degeneration Market Size & Forecast
7.3. Spain Age-Related Macular Degeneration Product Sales Forecast
7.4. Spain Age-Related Macular Degeneration Market Share Analysis

8. UK Age-Related Macular Degeneration Market Insights
8.1. Marketed Drugs for Age-Related Macular Degeneration in UK
8.2. UK Age-Related Macular Degeneration Market Size & Forecast
8.3. UK Age-Related Macular Degeneration Product Sales Forecast
8.4. UK Age-Related Macular Degeneration Market Share Analysis

9. Europe Age-Related Macular Degeneration Market Insights
9.1. Europe Age-Related Macular Degeneration Market Size & Forecast
9.2. Europe Age-Related Macular Degeneration Product Sales Forecast
9.3. Europe Age-Related Macular Degeneration Market Share Analysis

10. Research Methodology

List of Tables
Table 1: Age-Related Macular Degeneration Phase 3 Clinical Trials, Global, 2020
Table 2: Age-Related Macular Degeneration Phase 2 Clinical Trials, Global, 2020
Table 3: Age-Related Macular Degeneration Phase 1 Clinical Trials, Global, 2020
Table 4: Age-Related Macular Degeneration Prevalence by Countries, 2016 - 2024
Table 5: Marketed Drugs for Age-Related Macular Degeneration in Germany, 2019
Table 6: Germany Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 7: Germany Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 8: Germany Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 9: Marketed Drugs for Age-Related Macular Degeneration in France, 2019
Table 10: France Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 11: France Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 12: France Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 13: Marketed Drugs for Age-Related Macular Degeneration in Italy, 2019
Table 14: Italy Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 15: Italy Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 16: Italy Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 17: Marketed Drugs for Age-Related Macular Degeneration in Spain, 2019
Table 18: Spain Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 19: Spain Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 20: Spain Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 21: Marketed Drugs for Age-Related Macular Degeneration in UK, 2019
Table 22: UK Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 23: UK Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Table 24: UK Age-Related Macular Degeneration Market Events and Trends, 2016 - 2024
Table 25: Europe Age-Related Macular Degeneration Market Size & Forecast ($mn), 2016 - 2024
Table 26: Europe Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024

List of Figures
Figure 1: Age-Related Macular Degeneration Pipeline by Phase (%), Global, 2020
Figure 2: Age-Related Macular Degeneration Prevalence by Countries, 2016 - 2024
Figure 3: Germany Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 4: Germany Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 5: Germany Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 6: Germany Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 7: France Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 8: France Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 9: France Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 10: France Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 11: Italy Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 12: Italy Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 13: Italy Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 14: Italy Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 15: Spain Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 16: Spain Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 17: Spain Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 18: Spain Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 19: UK Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 20: UK Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 21: UK Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 22: UK Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Figure 23: Europe Age-Related Macular Degeneration Market Size ($mn), 2016 - 2024
Figure 24: Europe Age-Related Macular Degeneration Product Sales ($mn), 2016 - 2024
Figure 25: Europe Age-Related Macular Degeneration Market Share by Drugs (%), 2019
Figure 26: Europe Age-Related Macular Degeneration Market - Future Market Share (%), 2024
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll